View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
August 16, 2019updated 22 Dec 2019 3:32pm

IQVIA enables direct patient access to trial information

IQVIA has launched a new web-based solution to offer patients a direct access point for clinical trial information following their enrolment.

IQVIA has launched a new web-based solution to offer patients a direct access point for clinical trial information following their enrolment.

The IQVIA Patient Portal is expected to improve patient recruitment, engagement, and retention through better transparency and alliance.

After a patient is recruited into a trial, the portal assists through the process by providing study visit and medication reminders, as well as disease education. It also offers concierge and travel support services.

Patients will also have access to their individual lab results and additional study information permitted by the sponsor and investigator.

IQVIA Patient Portal will deliver a study summary to the patients after the completion of the trial. Patients can also choose to join an alumni community to track any participation opportunities in the future.

In addition, IQVIA has created retention solutions customised for individual clinical trial locations with study-level content.

IQVIA Research & Development Solutions Design and Delivery Innovation president Cynthia Verst said: “Patient communities are clear about what matters most to them, roughly 90% want access to information about their participation in the study including updates about the outcome of a study.

“IQVIA’s Patient Portal increases patient understanding and engagement during the trial and reduces the substantial cost associated with patients dropping out of a trial or being unavailable for follow-up.”

The company, which formed via the IMS Health and Quintiles merger, provides life sciences technology solutions, advanced analytics, and contract research services.

In February this year, IQVIA launched two capabilities aimed at improving the sharing of cross-trial training materials and safety notifications between clinical teams.

The cross-trial functionality can be used to communicate with sites across different studies, geographic locations and site roles.

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU